Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients Following Treatment With 20 Mg/Kg Liposomal Amphotericin B (Ambisome) in Bihar, India

PLoS Neglected Tropical Diseases - United States
doi 10.1371/journal.pntd.0002536
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Pharmacokinetics of Liposomal Amphotericin B (Ambisome) in Critically Ill Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Low Dose Liposomal Amphotericin B Seems to Be Effective Against Visceral Leishmaniasis

BMJ
2001English

Treatment of Experimental Visceral Leishmaniasis With Amphotericin B in Stable Albumin Microspheres

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Liposomal Amphotericin B (AmBisome) in the Treatment of Complicated Kala-Azar Under Field Conditions

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
1995English

Asymptomatic Infection With Visceral Leishmaniasis in a Disease-Endemic Area in Bihar, India

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2010English

Field Effectiveness of New Visceral Leishmaniasis Regimens After 1 Year Following Treatment Within Public Health Facilities in Bihar, India

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2019English

Therapeutic and Immunomodulatory Activities of Short-Course Treatment of Murine Visceral Leishmaniasis With KALSOME™10, a New Liposomal Amphotericin B

BMC Infectious Diseases
Infectious Diseases
2015English

Safety and Effectiveness of Amphotericin B Deoxycholate for the Treatment of Visceral Leishmaniasis in Uganda

Annals of Tropical Medicine & Parasitology
2008English

A Controlled, Randomized Nonblinded Clinical Trial to Assess the Efficacy of Amphotericin B Deoxycholate as Compared to Pentamidine for the Treatment of Antimony Unresponsive Visceral Leishmaniasis Cases in Bihar, India

Therapeutics and Clinical Risk Management
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy